Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.

HIV medicine - 1 Mar 2010

Orkin C, Sadiq S T, Rice L, Jackson F

Abstract excerpt

OBJECTIVES: Human leukocyte antigen (HLA)-B(*)5701 is strongly associated with developing a hypersensitivity reaction to abacavir (ABC) in White and Hispanic subjects. Across the UK, limited data exist on HLA-B(*)5701 prevalence in HIV-1-infected subjects. We determined HLA-B(*)5701 prevalence in the general HIV-1-infected population and in specific ethnic groups, particularly Black Africans who, in general,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Africa
Share to Anti-HIV Agents
Share to Black People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dideoxynucleosides

Share to Drug Hypersensitivity

Share to Epidemiologic Studies

Share to HLA-B Antigens

Share to United Kingdom

Source

Identifiers

PMID: 19780860
DOI: 10.1111/j.1468-1293.2009.00762.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.PMID 19780860Read ↗

An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in Europe.Semantic proximity Read ↗

Prevalence of Human Leukocyte Antigen HLA-B*57:01 in Individuals with HIV in West and Central AfricaSemantic proximity Read ↗

Prevalence of human leukocyte antigen HLA-B*57:01 in individuals with HIV in West and Central Africa.Semantic proximity Read ↗

Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART.Semantic proximity Read ↗

HLA-B*57:01 allele prevalence in HIV-infected North American subjects and the impact of allele testing on the incidence of abacavir-associated hypersensitivity reaction in HLA-B*57:01-negative subjectsSemantic proximity Read ↗

Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot studySemantic proximity Read ↗

High Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers among HIV-Infected Patients in Serbia.Semantic proximity Read ↗

Prevalence of HLA-B*57:01 and complete linkage disequilibrium with HCP5 rs2395029: Prevalence and DetectionSemantic proximity Read ↗

Human leukocyte antigen HLA-B*57:01 status in HIV-1 patients developing hypersensitivity reactions in Benin: a pilot study.Semantic proximity Read ↗

Frequency of Human Leukocyte Antigen-B*57:01 Allele Carriers in People Living with HIV/AIDS in Türkiye.Semantic proximity Read ↗

External quality assessment of patient HLA-B*57:01 testing prior to abacavir prescription.Semantic proximity Read ↗

External quality assessment of HLA-B*5701 reporting: an international multicentre survey.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.